1. Home
  2. UG vs AYTU Comparison

UG vs AYTU Comparison

Compare UG & AYTU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo United-Guardian Inc.

UG

United-Guardian Inc.

N/A

Current Price

$6.25

Market Cap

30.2M

ML Signal

N/A

Logo Aytu BioPharma Inc.

AYTU

Aytu BioPharma Inc.

N/A

Current Price

$2.61

Market Cap

25.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
UG
AYTU
Founded
1942
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Package Goods/Cosmetics
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
30.2M
25.7M
IPO Year
1995
2015

Fundamental Metrics

Financial Performance
Metric
UG
AYTU
Price
$6.25
$2.61
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$9.33
AVG Volume (30 Days)
2.8K
44.8K
Earning Date
05-07-2026
05-13-2026
Dividend Yield
7.99%
N/A
EPS Growth
N/A
N/A
EPS
0.20
N/A
Revenue
$12,181,971.00
$27,632,080.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$43.75
P/E Ratio
$32.40
N/A
Revenue Growth
11.91
277.47
52 Week Low
$5.58
$0.95
52 Week High
$9.88
$3.07

Technical Indicators

Market Signals
Indicator
UG
AYTU
Relative Strength Index (RSI) 40.87 55.21
Support Level $5.58 $2.14
Resistance Level $6.78 $2.66
Average True Range (ATR) 0.13 0.10
MACD -0.03 0.00
Stochastic Oscillator 21.92 62.50

Price Performance

Historical Comparison
UG
AYTU

About UG United-Guardian Inc.

United-Guardian Inc manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and specialty industrial products. Its product portfolio includes Klensoft, Deselex, Renacidin, Lubrajel Fluid. The company's pharmaceutical products are sold to and distributed by full-line drug wholesalers throughout the United States. Its medical and specialty industrial products are sold directly by the company to the end-users of those products or, in some cases, to contract manufacturers used by some of those end users. It operates in one business segment and its current product lines are separated into four distinct product categories that are cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. It derives key revenue from the sales made in the U.S.

About AYTU Aytu BioPharma Inc.

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline, including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates one business segment consisting of various prescription pharmaceutical products sold through third parties.

Share on Social Networks: